CCP
EW icon

Clarity Capital Partners’s Edwards Lifesciences EW Stock Holding History

Clarity Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$645K Sell
8,248
-672
-8% -$50.1K 0.23% 44
2025
Q1 		$647K Sell
8,920
-2,222
-20% -$159K 0.26% 53
2024
Q4 		$825K Buy
11,142
+1,973
+22% +$138K 0.43% 48
2024
Q3 		$605K Buy
9,169
+1,312
+17% +$95.3K 0.36% 62
2024
Q2 		$726K Buy
7,857
+2,531
+48% +$224K 0.44% 52
2024
Q1 		$509K Sell
5,326
-360
-6% -$30.2K 0.33% 68
2023
Q4 		$434K Buy
+5,686
New +$396K 0.3% 69

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Clarity Capital Partners's EW Position: Q2 2025 in Review

Clarity Capital Partners reduced its Edwards Lifesciences (EW) stake by 7.5% in Q2 2025, selling an estimated $50.1K and leaving 8,248 shares worth $645K. The position accounts for 0.23% of the portfolio, ranked #44.

Clarity Capital Partners first reported a position in EW in Q4 2023 and has held it in 7 quarters since. The position peaked at $825K in Q4 2024. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Clarity Capital Partners held 8,248 shares of Edwards Lifesciences worth $645K as of Q2 2025.
  • Clarity Capital Partners sold 672 Edwards Lifesciences shares in Q2 2025, an estimated $50.1K.
  • Edwards Lifesciences made up 0.23% of Clarity Capital Partners's portfolio in Q2 2025, its #44 holding.
  • Clarity Capital Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 7 quarters since.
  • Clarity Capital Partners's Edwards Lifesciences position peaked at $825K in Q4 2024.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Clarity Capital Partners's 13F filing for Q2 2025, filed 21 Jul 2025.